Red light therapy is a low-level photobiomodulation treatment used to target skin issues including wrinkles, redness, acne, and scars [1, 2].
The rise of the therapy in dermatology clinics and at-home devices in the U.S. and internationally reflects a growing consumer demand for non-invasive skin care. However, the gap between commercial marketing and clinical verification creates a challenge for patients seeking evidence-based medical treatments.
Researchers and clinicians study the process to determine how red wavelengths stimulate cellular activity and collagen production [1, 3]. While the therapy gained significant commercial popularity in the early 2020s [1, 3], the medical community remains divided on its actual efficacy.
Some medical institutions, such as the Cleveland Clinic, describe the treatment as an emerging option that shows promise for signs of aging [4]. Conversely, other scientific perspectives suggest that many of the claimed benefits are overhyped and that the therapy does not live up to all advertised claims [5].
This discrepancy extends to the range of conditions the therapy is marketed to treat. While some clinicians focus on skin-related issues like scars and acne [4], the technology is also marketed for hair loss, depression, and chronic pain [5]. Many of these broader applications lack solid evidence [5].
Beyond skin care, photobiomodulation has been explored in more severe medical contexts. In 2021 [6], dermatologist David Ozog's son, who was 18 years old [7], suffered a massive stroke while on holiday, highlighting the broader clinical interest in how light-based therapies might interact with neurological recovery.
Despite these explorations, researchers said more clinical trials are needed to confirm the effectiveness of the treatment [1, 3].
“Red light therapy is a low-level photobiomodulation treatment that targets skin concerns.”
The tension between the rapid commercialization of red light therapy and the slower pace of clinical validation suggests a market driven by consumer trends rather than medical consensus. While it may offer limited healing powers for specific skin conditions, its expansion into treating systemic issues like depression or chronic pain remains speculative without robust, peer-reviewed data.
